BUY Prestige Estates Projects — Manas Jaiswal
Prestige Estates Projects share price target & all analyst calls
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))7 Jul 2026via CNBC Awaaz.
Entry₹1,715Inferred
Stop loss₹1,625-5.25% risk
Exit₹1,6258 Jul 2026, 2:50 pm
Stop-loss hit-5.25%
Follow Manas Jaiswal for new calls(30% target hit, 380 closed calls)Get alertsWatch PRESTIGE for new buy/sell callsGet alertsSee 1 active Swing call on PRESTIGESee 149 active Swing picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting0 opposing
Supports the BUY call (1)
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Prestige Estates Projects
- SELL — Ashish Bahety, Profitmart Securities23 Oct 2026 · Same day · target ₹1,360 · Expired
- SELL — Sachin Gupta23 Oct 2026 · ~2 weeks · target ₹1,350 · Active
- BUY — Sumeet Bagadia, Choice Broking16 Oct 2026 · ~2 weeks · target ₹1,520 · SL hit
- BUY — Ashish Bahety, Profitmart Securities16 Oct 2026 · ~2 weeks · target ₹1,520 · SL hit
- BUY — HSBC Securities14 Oct 2026 · ~1 year · target ₹2,050 · Active
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

